References
- Blaney SM, Balis FM, Poplack DG. Pharmacologic approaches to the treatment of meningeal malignancy. Oncology 1991; 5: 107–127
- Kalifa C, Hartmann O, Demeaq F, et al. High-dose busulfan and thiotepa with autologous bone marrow transplantation in childhood malignant brain tumors: a phase II study. Bone Marrow Transplant 1992; 9: 227–233
- Chamberlain MC. New approaches to and current treatment of leptomeningeal metastases. Curr Opin Neurol. 1994; 7: 492–500
- Berg SL, Poplack DG. Advances in the treatment of meningeal cancers. Crit Rev Oncol Hematol. 1995; 20: 87–98
- Iacoangeli M, Roselli R, Pagano L, et al. Intrathecal chemotherapy for treatment of overt meningeal leukemia: comparison between intraventricular and traditional intralumbar route. Ann Oncol. 1995; 6: 377–382
- Portnoy HD, Schulte RR, Fox JL, Croissant PD, Tripp L. Anti-siphon and reversible occlusion valves for shunting in hydrocephalus and preventing post-shunt subdural hematomas. J Neurosurg. 1973; 38: 729–738
- Kleihues P, Burger OC, Scheithauer BW. Histologic Typing of Tumors of the Central Nervous System. Springer-Verlag, Berlin 1993
- Blaney S, Balis F, Murphy R, Arndt C, Gillespie A, Poplack D. A phase I study of intrathecal mafos-famide in patients with refractory meningeal malignancy. Proc Am Soc Clin Oncol. 1992; 11: 274
- Slave I, Schuller E, Seidl R, Czech T, Dieckmann K. Intraventricular mafosfamide in pediatric brain tumor patients with meningeal dissemination. Med Pediatr Oncol. 1996; 27: 324